| scholarly article | Q13442814 |
| P50 | author | David Dingli | Q66385573 |
| Robert A Kyle | Q66385695 | ||
| Martha Q Lacy | Q66419394 | ||
| Shaji K Kumar | Q85960198 | ||
| Mark R Litzow | Q87294607 | ||
| Michelle Elliott | Q87973970 | ||
| Dennis A Gastineau | Q88014326 | ||
| Stephen M Ansell | Q88316326 | ||
| Luis F Porrata | Q88344731 | ||
| Francis K Buadi | Q88774336 | ||
| Suzanne R Hayman | Q96475488 | ||
| Ivana N M Micallef | Q114300400 | ||
| Angela Dispenzieri | Q37838558 | ||
| David J. Inwards-Breland | Q39729621 | ||
| Alan H. Bryce | Q50576221 | ||
| Morie A Gertz | Q57052163 | ||
| P2093 | author name string | Bekele Afessa | |
| William J Hogan | |||
| Patrick A Johnston | |||
| P2860 | cites work | Marrow engraftment and clinical manifestations of capillary leak syndrome | Q71592644 |
| Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support | Q72078445 | ||
| Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome | Q73071321 | ||
| Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome | Q74428185 | ||
| Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation | Q74492531 | ||
| Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease | Q74624130 | ||
| Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome | Q77407534 | ||
| High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome | Q77870040 | ||
| Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support | Q80033298 | ||
| Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation | Q82971703 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou | Q33340726 | ||
| POEMS syndrome | Q34006873 | ||
| POEMS syndrome: an unusual cause of bilateral optic disk swelling | Q34067473 | ||
| POEMS syndrome: definitions and long-term outcome | Q34161383 | ||
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| International uniform response criteria for multiple myeloma. | Q34549410 | ||
| Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature | Q35848803 | ||
| Recurrent Crow-Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature | Q36640695 | ||
| Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection | Q40517545 | ||
| Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria | Q40563612 | ||
| Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. | Q40661944 | ||
| Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation | Q40683151 | ||
| Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis | Q42480315 | ||
| Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation | Q43728175 | ||
| Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation | Q44165604 | ||
| Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome | Q46568950 | ||
| Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy. | Q50706827 | ||
| Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue. | Q51142114 | ||
| Peripheral blood stem cell transplantation for POEMS syndrome. | Q53670848 | ||
| Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. | Q53988380 | ||
| A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables | Q56432190 | ||
| Autologous peripheral blood stem cell transplantation for POEMS syndrome | Q56772166 | ||
| P433 | issue | 5 | |
| P921 | main subject | POEMS syndrome | Q2553422 |
| stem cell transplantation | Q65592366 | ||
| P304 | page(s) | 397-406 | |
| P577 | publication date | 2008-01-23 | |
| P1433 | published in | European Journal of Haematology | Q15765799 |
| P1476 | title | Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome | |
| P478 | volume | 80 |
| Q64242483 | A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation |
| Q40306199 | Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis |
| Q52988248 | Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis. |
| Q38608362 | Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience. |
| Q47790104 | Advances in the Treatment of Paraproteinemic Neuropathy |
| Q45455016 | Alcohol Misuse Link to POEMS Syndrome in a Patient |
| Q33867198 | Amyloidosis and POEMS syndrome |
| Q42645569 | An unusual case of myocardial infarction |
| Q38248359 | Autologous hematopoietic cell transplantation: an update for clinicians |
| Q82458862 | Autologous peripheral blood stem cell transplantation in a patient with POEMS syndrome |
| Q91782633 | Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study |
| Q35067588 | Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome |
| Q36264701 | Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach |
| Q34079430 | Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. |
| Q43198285 | Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center |
| Q38315390 | Engraftment syndrome: double-edged sword of hematopoietic cell transplants |
| Q56771820 | Factors associated with the efficiency of PBSC collection in POEMS syndrome patients undergoing autologous PBSC transplantation |
| Q37555831 | High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplant |
| Q36181433 | How I treat POEMS syndrome |
| Q39013670 | Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome. |
| Q88506851 | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation |
| Q88219193 | Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome |
| Q38080588 | New advances in the diagnosis and treatment of POEMS syndrome. |
| Q47714833 | Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation |
| Q47350403 | PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors |
| Q46425925 | POEMS SYNDROME: an Update |
| Q34553376 | POEMS Syndrome: an Enigma |
| Q41964363 | POEMS syndrome - a unique presentation of a rare paraneoplastic syndrome. |
| Q37890982 | POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management |
| Q34404620 | POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management |
| Q34558653 | POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management |
| Q34492003 | POEMS syndrome: update on diagnosis, risk-stratification, and management |
| Q53791232 | Paraproteinemic neuropathy. |
| Q40328164 | Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring |
| Q99730640 | Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation |
| Q36593400 | Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome |
| Q40093870 | Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. |
| Q46222428 | Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome |
| Q45747998 | Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation |
| Q40347834 | Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome |
| Q24202634 | Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome |
| Q24241063 | Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome |
| Q37733512 | Treatment in inflammatory neuropathies |
| Q91283890 | What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone? |
Search more.